Funded Startups in Melville
Six recently disclosed Melville-based rounds span 2021-10-18 to 2025-07-18, with the most recent being NanoVibronix (Health Care) at $9M on 2025-07-18.
Six recently disclosed Melville-based rounds span 2021-10-18 to 2025-07-18, with the most recent being NanoVibronix (Health Care) at $9M on 2025-07-18. A sharp outlier stands out on the upper end: Comtech Telecommunications’ $100M Post-IPO Equity round (2021-10-18) is far above the next-largest disclosed amount, Orthocell’s $11M (2024-10-25), while three other disclosed amounts cluster much closer together at $9M–$11M. Sector concentration is visible as well: Biotechnology and Health Care together account for four of the six entries (Orthocell, Altro Pharmaceuticals, Amici Pharmaceuticals, NanoVibronix), and two of six entries list amounts as “undisclosed” (The Wealth Alliance on 2025-01-28; Altro Pharmaceuticals and Amici Pharmaceuticals on 2024-09-18). Dates also form a mid-2024 cluster, with two Biotechnology/Pharma events landing on 2024-09-18 and another on 2024-10-25. Geography stays tied to “Melville,” with one listing in Melville, Western Australia (Orthocell) versus five in Melville, New York (including NanoVibronix, The Wealth Alliance, Altro Pharmaceuticals, Amici Pharmaceuticals, and Comtech Telecommunications).
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round in Melville here, and how does it stack up against the rest?
Comtech Telecommunications’ $100M Post-IPO Equity round (2021-10-18) is an outlier, well above the next-largest disclosed amount of $11M (Orthocell on 2024-10-25); the other disclosed figures shown are $9M and remain in the single-digit to low-teens range.
Do the rounds cluster in time, or are they spread evenly across the period shown?
The set spans 2021-10-18 through 2025-07-18, but several events cluster in 2024: two rounds are dated 2024-09-18 (Altro Pharmaceuticals and Amici Pharmaceuticals, both undisclosed) and another appears on 2024-10-25 (Orthocell, $11M).
Are any sectors over-represented among these six Melville entries?
Biotechnology and Health Care dominate: Biotechnology appears in three entries (Orthocell, Altro Pharmaceuticals, Amici Pharmaceuticals) and Health Care appears in two (NanoVibronix and Amici Pharmaceuticals), totaling four of six entries across those two verticals.
How much of the list is “Series Unknown” versus other stage labels, and does that affect disclosed sizing?
Five of six rows are labeled “Series Unknown” (including NanoVibronix $9M on 2025-07-18, Orthocell $11M on 2024-10-25, and multiple undisclosed rounds in 2024-09-18), while only Comtech Telecommunications is labeled Post-IPO Equity with $100M on 2021-10-18.
Which entries were filed as “undisclosed,” and how does that compare to the disclosed amount range?
Three rows carry “undisclosed” amounts: The Wealth Alliance (2025-01-28), Altro Pharmaceuticals (2024-09-18), and Amici Pharmaceuticals (2024-09-18). The disclosed amounts shown otherwise run from $9M (NanoVibronix, 2025-07-18) up to $11M (Orthocell, 2024-10-25), excluding Comtech’s $100M outlier.
Is there any geographic pattern within “Melville,” or are these mostly in the same jurisdiction?
Five of six entries specify Melville, New York (NanoVibronix; The Wealth Alliance; Altro Pharmaceuticals; Amici Pharmaceuticals; Comtech Telecommunications), while Orthocell is the lone entry in Melville, Western Australia (2024-10-25, $11M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.